List of insiders holdings for Arcutis Biotherapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| Frazier Life Sciences VIII L.P. FHM LIFE SCIENCES VIII L.P. FHM LIFE SCIENCES VIII L.L.C. Topper James N Heron Patrick J 10% Owner | 2024-03-06 12:40:25 | 8,862,478 0 | 8,862,478 | Form 13D |
| Heron Patrick J Director | 2024-03-06 16:28:21 | 8687 8,808,979 | 8,817,666 | Form 4 |
| ORBIMED ADVISORS LLC ORBIMED CAPITAL LLC OrbiMed Capital GP VII LLC 10% Owner | 2022-08-26 16:12:59 | 2,828,356 0 | 2,828,356 | Form 13D |
| Bain Capital Life Sciences Investors LLC Bain Capital Life Sciences Partners LP Bain Capital Life Sciences Fund L.P. BCIP Life Sciences Associates LP Koppel Adam Schwartz Jeffrey Lawrence 10% Owner | 2022-08-08 16:49:59 | 2,721,436 0 | 2,721,436 | Form 13D |
| Watanabe Todd Franklin See Remarks | 2024-05-03 16:22:53 | 860,750 231,140 | 1,091,890 | Form 4 |
| CHAUDHURI BHASKAR Director | 2023-06-02 19:13:43 | 862,298 49,981 | 912,279 | Form 4 |
| SILVERSTEIN JONATHAN Director 10% Owner | 2020-10-06 17:23:56 | 0 902,286 | 902,286 | Form 4 |
| Topper David Joseph Chief Financial Officer | 2024-04-11 20:32:50 | 420,000 0 | 420,000 | Form 4 |
| OSBORNE DAVID W Chief Technical Officer | 2023-03-08 16:26:13 | 268,854 0 | 268,854 | Form 4 |
| Edwards Larry Todd Chief Commercial Officer | 2024-01-17 16:34:23 | 264,000 0 | 264,000 | Form 4 |
| Burnett Patrick See Remarks | 2024-05-03 16:22:18 | 259,745 0 | 259,745 | Form 4 |
| Welgus Howard G. Director | 2023-06-02 18:54:36 | 182,420 24,991 | 207,411 | Form 4 |
| Matsuda Masaru See Remark | 2024-05-03 16:22:39 | 185,408 0 | 185,408 | Form 4 |
| Smither John W Chief Financial Officer | 2024-02-15 18:23:45 | 11,365 141,392 | 152,757 | Form 4 |
| Moore Matthew Richard SVP and Chief Business Officer | 2024-05-03 16:29:15 | 145,505 0 | 145,505 | Form 4 |
| Lock Kenneth A. Chief Commercial Officer | 2023-03-08 16:25:29 | 63,429 0 | 63,429 | Form 4 |
| Turney Patricia A. SVP, Operations | 2023-03-08 16:26:49 | 62,862 0 | 62,862 | Form 4 |
| Burrows Scott L Chief Financial Officer | 2023-03-08 16:29:15 | 59,115 0 | 59,115 | Form 4 |
| ESTES DANIEL Director | 2020-03-03 20:59:31 | 24,000 0 | 24,000 | Form 4 |
| Leonard Keith R Director | 2023-06-02 19:02:40 | 20,907 1750 | 22,657 | Form 4 |
| LIN SUE-JEAN Director | 2023-06-02 19:22:20 | 21,207 0 | 21,207 | Form 4 |
| Curran Terrie Director | 2023-06-02 19:10:55 | 20,907 0 | 20,907 | Form 4 |
| Gilbert Halley E Director | 2023-06-02 19:08:02 | 20,907 0 | 20,907 | Form 4 |
| Krishnamohan Neha Director | 2023-06-02 18:59:26 | 17,827 0 | 17,827 | Form 4 |
| TURNER JOSEPH L Director | 2022-06-03 16:51:53 | 16,108 0 | 16,108 | Form 4 |
| Sun Ricky Director | 2021-06-11 17:30:15 | 13,391 0 | 13,391 | Form 4 |
| Asam Alexander Director | 2020-01-30 19:54:50 | 0 0 | 0 | Form 3 |